Angiotensin II type 1 receptor-mediated reduction of angiotensin-converting enzyme 2 activity in the brain impairs baroreflex function in hypertensive mice

scientific article published on 05 January 2009

Angiotensin II type 1 receptor-mediated reduction of angiotensin-converting enzyme 2 activity in the brain impairs baroreflex function in hypertensive mice is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/HYPERTENSIONAHA.108.123844
P932PMC publication ID2695598
P698PubMed publication ID19124678

P50authorYumei FengQ61731773
P2093author name stringEric Lazartigues
Huijing Xia
Peter J Hickman
Teresa D Obr
P2860cites workCloning and characterization of a secreted form of angiotensin-converting enzyme 2Q24304865
Angiotensin-converting enzyme 2 overexpression in the subfornical organ prevents the angiotensin II-mediated pressor and drinking responses and is associated with angiotensin II type 1 receptor downregulationQ24311938
Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor MasQ24680069
Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidaseQ28115041
Angiotensin-converting enzyme 2 is an essential regulator of heart functionQ28205840
The two fACEs of the tissue renin-angiotensin systems: implication in cardiovascular diseasesQ28302418
Angiotensin AT2 receptors: control of renal sodium excretion and blood pressureQ30445660
Physiology of local renin-angiotensin systems.Q34543927
Angiotensin peptides as neurotransmitters/neuromodulators in the dorsomedial medullaQ34636700
Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin systemQ35567432
The CNS renin-angiotensin systemQ36429075
Enhanced water and salt intake in transgenic mice with brain-restricted overexpression of angiotensin (AT1) receptors.Q36977221
Chronic central leptin infusion restores cardiac sympathetic-vagal balance and baroreflex sensitivity in diabetic ratsQ37038877
Angiotensin-converting enzyme 2 in the brain: properties and future directionsQ37155907
Injections of angiotensin-converting enzyme 2 inhibitor MLN4760 into nucleus tractus solitarii reduce baroreceptor reflex sensitivity for heart rate control in ratsQ37247541
Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes.Q37352071
Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review.Q41621710
Differential baroreceptor reflex modulation by centrally infused angiotensin peptidesQ42462109
Participation of AT1 and AT2 receptor subtypes in the tonic inhibitory modulation of baroreceptor reflex response by endogenous angiotensins at the nucleus tractus solitarii in the rat.Q42544169
Upregulation of angiotensin-converting enzyme 2 by all-trans retinoic acid in spontaneously hypertensive ratsQ45101312
Sympathoexcitation by central ANG II: roles for AT1 receptor upregulation and NAD(P)H oxidase in RVLM.Q45214773
Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.Q46493539
Impaired heart rate baroreflex in older rats: role of endogenous angiotensin-(1-7) at the nucleus tractus solitariiQ46595087
Effects of angiotensin type 2 receptor overexpression in the rostral ventrolateral medulla on blood pressure and urine excretion in normal ratsQ46845265
Increased concentration of angiotensin II binding sites in selected brain areas of spontaneously hypertensive ratsQ48132473
Overexpression of angiotensin-converting enzyme 2 in the rostral ventrolateral medulla causes long-term decrease in blood pressure in the spontaneously hypertensive ratsQ48260358
The brain renin-angiotensin system contributes to the hypertension in mice containing both the human renin and human angiotensinogen transgenesQ48350561
Angiotensin II acts at AT1 receptors in the nucleus of the solitary tract to attenuate the baroreceptor reflexQ48365574
Long-term telemetric measurement of cardiovascular parameters in awake mice: a physiological genomics tool.Q51363570
EFFECT OF AN ANTIHYPERTENSIVE DRUG ON BRAIN ANGIOTENSIN II LEVELS IN RENAL AND SPONTANEOUSLY HYPERTENSIVE RATSQ58363962
Baroreceptor Reflex Sensitivity Estimated by the Sequence Technique is Reliable in RatsQ60731517
Evaluation of the baroreceptor-heart rate reflex by 24-hour intra-arterial blood pressure monitoring in humansQ68487763
Neuro-cardiovascular regulation: from molecules to man. IntroductionQ74218884
Renovascular hypertension in mice with brain-selective overexpression of AT1a receptors is buffered by increased nitric oxide production in the peripheryQ80396565
P433issue2
P407language of work or nameEnglishQ1860
P304page(s)210-216
P577publication date2009-01-05
P1433published inHypertensionQ5958695
P1476titleAngiotensin II type 1 receptor-mediated reduction of angiotensin-converting enzyme 2 activity in the brain impairs baroreflex function in hypertensive mice
P478volume53

Reverse relations

cites work (P2860)
Q24306614A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme
Q92946509ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer's disease
Q50464178ACE2 activity was increased in atherosclerotic plaque by losartan: Possible relation to anti-atherosclerosis
Q100558878ACE2 mouse models: a toolbox for cardiovascular and pulmonary research
Q35776364ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension
Q40159156ACE2-Ang-(1-7)-Mas Axis in Brain: A Potential Target for Prevention and Treatment of Ischemic Stroke
Q33983361ACE2-mediated reduction of oxidative stress in the central nervous system is associated with improvement of autonomic function
Q34784864ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.
Q90046431Activation of ADAM17 (A Disintegrin and Metalloprotease 17) on Glutamatergic Neurons Selectively Promotes Sympathoexcitation
Q34158064Activation of the ACE2/Ang-(1-7)/Mas pathway reduces oxygen-glucose deprivation-induced tissue swelling, ROS production, and cell death in mouse brain with angiotensin II overproduction
Q36501950Aldosterone acting through the central nervous system sensitizes angiotensin II-induced hypertension
Q89006965Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
Q34510691Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor-dependent mechanism.
Q34496676Angiotensin II receptors and drug discovery in cardiovascular disease
Q28592286Angiotensin II regulates ACE and ACE2 in neurons through p38 mitogen-activated protein kinase and extracellular signal-regulated kinase 1/2 signaling
Q35707198Angiotensin II-induced hypertension is modulated by nuclear factor-κBin the paraventricular nucleus.
Q36825182Angiotensin converting enzyme 2/Ang-(1-7)/mas axis protects brain from ischemic injury with a tendency of age-dependence
Q36020040Angiotensin converting enzyme 2: a new important player in the regulation of glycemia
Q27022788Angiotensin peptides and nitric oxide in cardiovascular disease
Q21710697Angiotensin type 1 receptor inhibition enhances the extinction of fear memory
Q36267261Angiotensin-(1-7) protects against the development of aneurysmal subarachnoid hemorrhage in mice
Q37440125Angiotensin-converting enzyme 2 is reduced in Alzheimer's disease in association with increasing amyloid-β and tau pathology
Q34479181Angiotensin-converting enzyme 2 over-expression in the central nervous system reduces angiotensin-II-mediated cardiac hypertrophy
Q37079211Angiotensin-converting enzyme 2 overexpression improves central nitric oxide-mediated sympathetic outflow in chronic heart failure
Q40143632Angiotensin-converting enzyme 2: a new target for neurogenic hypertension
Q34978620Angiotensin-converting enzyme 2: central regulator for cardiovascular function
Q35550937Angiotensin-converting enzyme 2: the first decade
Q34423315Angiotensin-converting enzymes and drug discovery in cardiovascular diseases.
Q28081985Autonomic and inflammatory consequences of posttraumatic stress disorder and the link to cardiovascular disease
Q35138558Brain ACE2 overexpression reduces DOCA-salt hypertension independently of endoplasmic reticulum stress
Q35776904Brain angiotensin-converting enzyme type 2 shedding contributes to the development of neurogenic hypertension
Q36031907Brain-targeted (pro)renin receptor knockdown attenuates angiotensin II-dependent hypertension
Q89107401Central administration of TRV027 improves baroreflex sensitivity and vascular reactivity in spontaneously hypertensive rats
Q44894560Changes in gene expression in the frontal cortex of rats with pilocarpine-induced status epilepticus after sleep deprivation
Q42031141Chronic activation of endogenous angiotensin-converting enzyme 2 protects diabetic rats from cardiovascular autonomic dysfunction
Q34535805Chronic sleep restriction during pregnancy--repercussion on cardiovascular and renal functioning of male offspring
Q38781945Clinical Relevance and Role of Neuronal AT1 Receptors in ADAM17-Mediated ACE2 Shedding in Neurogenic Hypertension.
Q46894741Conversion of Aβ43 to Aβ40 by the successive action of angiotensin-converting enzyme 2 and angiotensin-converting enzyme
Q33795353From gene to protein-experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension
Q35601958Hypotensive and sympathoinhibitory responses to selective central AT2 receptor stimulation in spontaneously hypertensive rats
Q36733839Immunohistochemical Localization of AT1a, AT1b, and AT2 Angiotensin II Receptor Subtypes in the Rat Adrenal, Pituitary, and Brain with a Perspective Commentary
Q95845011Implications for Neuromodulation Therapy to Control Inflammation and Related Organ Dysfunction in COVID-19
Q34731058Inhibition of TNF in the brain reverses alterations in RAS components and attenuates angiotensin II-induced hypertension
Q51747739Integrative Physiological Aspects of Brain RAS in Hypertension.
Q43152722Losartan attenuates chronic cigarette smoke exposure-induced pulmonary arterial hypertension in rats: possible involvement of angiotensin-converting enzyme-2.
Q37712468Neuronal over-expression of ACE2 protects brain from ischemia-induced damage
Q37599394Not just angiotensinases: new roles for the angiotensin-converting enzymes
Q34322162Nox2 NADPH oxidase promotes pathologic cardiac remodeling associated with Doxorubicin chemotherapy
Q36764034Pancreatic angiotensin-converting enzyme 2 improves glycemia in angiotensin II-infused mice
Q38800189Perinatal Exposure to Western Diet Programs Autonomic Dysfunction in the Male Offspring
Q33510142Protective effects of PARP-1 knockout on dyslipidemia-induced autonomic and vascular dysfunction in ApoE mice: effects on eNOS and oxidative stress
Q90011350Role of brain renin angiotensin system in neurodegeneration: An update
Q35812259Sensitization of slow pressor angiotensin II (Ang II)-initiated hypertension: induction of sensitization by prior Ang II treatment
Q35543390Species-specific inhibitor sensitivity of angiotensin-converting enzyme 2 (ACE2) and its implication for ACE2 activity assays
Q99633068The Actin Bundling Protein Fascin-1 as an ACE2-Accessory Protein
Q92566054The Renin-Angiotensin System in the Central Nervous System and Its Role in Blood Pressure Regulation
Q33742540The central renin-angiotensin system and sympathetic nerve activity in chronic heart failure
Q26823573The compensatory renin-angiotensin system in the central regulation of arterial pressure: new avenues and new challenges
Q36114331α-Lipoic acid reduces neurogenic hypertension by blunting oxidative stress-mediated increase in ADAM17.

Search more.